Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Woolworths | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$37.11B | 342x | -3.65 | A$30.39 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.4% Upside | Upgrade to Pro+ | |
Coles Group | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$25.07B | 22.4x | 12.37 | A$18.80 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.5% Downside | Upgrade to Pro+ | |
Endeavour Group | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$7.54B | 18.6x | -4.56 | A$4.21 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.8% Upside | Upgrade to Pro+ | |
Metcash | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$3.46B | 12.9x | -0.95 | A$3.16 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.5% Upside | Upgrade to Pro+ | |
Jatcorp | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$39.14M | 17.4x | 0.09 | A$0.47 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Aumake | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$15.04M | -1.3x | 0.26 | A$0.005 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |